A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Candel Therapeutics, Inc.
Candel Therapeutics, Inc.
Brigham and Women's Hospital
The Methodist Hospital Research Institute
Nuvectis Pharma, Inc.
AstraZeneca
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Chicago
University of Milano Bicocca
University of Zurich
National Taipei University of Nursing and Health Sciences
AdventHealth
Jules Bordet Institute
First Affiliated Hospital of Fujian Medical University
Clinique Sainte Clotilde
Canadian Cancer Trials Group
University Health Network, Toronto
Martini-Klinik am UKE GmbH
Centre Hospitalier Universitaire de la Guadeloupe
Massachusetts General Hospital
Prostate Cancer Clinical Trials Consortium
Fox Chase Cancer Center
Rondo Therapeutics
Halda Therapeutics OpCo, Inc.
First Affiliated Hospital of Fujian Medical University
Tianjin Medical University Second Hospital
Brigham and Women's Hospital
Imperial College London
European Institute of Oncology
University Medical Center Groningen
Chinese University of Hong Kong
St. Antonius Hospital Gronau
Heinrich-Heine University, Duesseldorf
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University Hospital Ostrava
Cellvax Therapeutics Inc
University Health Network, Toronto
First Affiliated Hospital of Fujian Medical University